SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3dls'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AV2_B_DVAB8_0
(GRAMICIDIN A)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		3 / 3 VAL A1191
VAL A1228
TRP A1187
 None
 0.97A 1av2A-3dlsA:
undetectable
1av2B-3dlsA:
undetectable		 1av2A-3dlsA:
4.83
1av2B-3dlsA:
4.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_A_BAXA1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 LYS A1028
LEU A1056
ILE A1064
ILE A1124
 ADP  A   1 (-3.0A)
None
None
None
 0.64A 1uwjA-3dlsA:
7.5		 1uwjA-3dlsA:
26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W5U_B_DVAB8_0
(GRAMICIDIN D)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		3 / 3 VAL A1191
VAL A1228
TRP A1187
 None
 0.76A 1w5uA-3dlsA:
undetectable
1w5uB-3dlsA:
undetectable		 1w5uA-3dlsA:
4.83
1w5uB-3dlsA:
4.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVV_A_MK1A901_2
(POL POLYPROTEIN)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		3 / 3 ASP A1101
VAL A1220
PRO A1217
 None
 0.75A 2avvA-3dlsA:
undetectable		 2avvA-3dlsA:
13.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IZQ_C_DVAC8_0
(GRAMICIDIN D)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		3 / 3 VAL A1228
TRP A1187
VAL A1191
 None
 0.78A 2izqC-3dlsA:
undetectable
2izqD-3dlsA:
undetectable		 2izqC-3dlsA:
4.83
2izqD-3dlsA:
4.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ADS_A_IMNA2_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 ILE A1108
ILE A1065
LEU A1196
PHE A1109
 None
ADP  A   1 (-4.0A)
None
None
 1.14A 3adsA-3dlsA:
undetectable		 3adsA-3dlsA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U5K_B_08JB2_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 7 VAL A1265
LEU A1104
LEU A1100
ILE A1136
 None
 0.91A 3u5kB-3dlsA:
undetectable		 3u5kB-3dlsA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U5K_C_08JC3_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 8 VAL A1265
LEU A1104
LEU A1100
ILE A1136
 None
 0.91A 3u5kC-3dlsA:
undetectable		 3u5kC-3dlsA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U5K_D_08JD4_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 8 VAL A1265
LEU A1104
LEU A1100
ILE A1136
 None
 0.89A 3u5kD-3dlsA:
undetectable		 3u5kD-3dlsA:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WAR_A_NIOA401_1
(CASEIN KINASE II
SUBUNIT ALPHA)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		6 / 8 VAL A1013
VAL A1026
LYS A1028
ILE A1065
ILE A1145
ASP A1146
 ADP  A   1 ( 4.5A)
ADP  A   1 ( 4.4A)
ADP  A   1 (-3.0A)
ADP  A   1 (-4.0A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.49A 3warA-3dlsA:
24.0		 3warA-3dlsA:
25.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A9J_A_TYLA1188_1
(BROMODOMAIN
CONTAINING 2)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 5 VAL A1265
LEU A1104
LEU A1100
ILE A1136
 None
 0.94A 4a9jA-3dlsA:
undetectable		 4a9jA-3dlsA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A9J_B_TYLB1187_1
(BROMODOMAIN
CONTAINING 2)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 5 VAL A1265
LEU A1104
LEU A1100
ILE A1136
 None
 0.89A 4a9jB-3dlsA:
undetectable		 4a9jB-3dlsA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A9J_C_TYLC1184_1
(BROMODOMAIN
CONTAINING 2)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 5 VAL A1265
LEU A1104
LEU A1100
ILE A1136
 None
 0.90A 4a9jC-3dlsA:
undetectable		 4a9jC-3dlsA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AX8_A_SAMA1474_1
(WBDD)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 GLN A1253
ARG A1110
ASP A1101
GLU A1264
 None
 1.42A 4ax8A-3dlsA:
3.4		 4ax8A-3dlsA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AZV_A_SAMA1474_1
(WBDD)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 GLN A1253
ARG A1110
ASP A1101
GLU A1264
 None
 1.40A 4azvA-3dlsA:
10.3		 4azvA-3dlsA:
20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D32_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 8 PHE A1109
GLU A1185
SER A1188
MET A1186
 None
 1.35A 4d32A-3dlsA:
undetectable
4d32B-3dlsA:
undetectable		 4d32A-3dlsA:
21.36
4d32B-3dlsA:
21.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4I41_A_MIXA500_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		7 / 12 VAL A1013
ILE A1065
ASP A1089
ASP A1128
ASN A1133
ILE A1145
ASP A1146
 ADP  A   1 ( 4.5A)
ADP  A   1 (-4.0A)
ADP  A   1 (-3.9A)
None
MG  A   7 ( 3.1A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.65A 4i41A-3dlsA:
31.4		 4i41A-3dlsA:
31.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4I41_A_MIXA501_1
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		5 / 12 ILE A1094
LYS A1130
ASP A1131
THR A1165
GLU A1205
 None
 0.88A 4i41A-3dlsA:
31.4		 4i41A-3dlsA:
31.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IQQ_D_D16D402_1
(THYMIDYLATE SYNTHASE)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 8 LYS A1023
ILE A1065
ASP A1069
LEU A1068
 None
ADP  A   1 (-4.0A)
None
None
 0.77A 4iqqD-3dlsA:
undetectable		 4iqqD-3dlsA:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WGQ_A_ESTA601_1
(ESTROGEN RECEPTOR)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		5 / 9 GLU A1185
LEU A1189
ARG A1120
GLY A1230
LEU A1232
 None
 1.48A 5wgqA-3dlsA:
undetectable		 5wgqA-3dlsA:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9M_A_NIOA401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		6 / 8 LEU A1005
VAL A1013
VAL A1026
LYS A1028
ILE A1145
ASP A1146
 ADP  A   1 (-4.1A)
ADP  A   1 ( 4.5A)
ADP  A   1 ( 4.4A)
ADP  A   1 (-3.0A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.60A 5y9mA-3dlsA:
24.2		 5y9mA-3dlsA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y9M_X_NIOX401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		6 / 8 LEU A1005
VAL A1013
VAL A1026
LYS A1028
ILE A1145
ASP A1146
 ADP  A   1 (-4.1A)
ADP  A   1 ( 4.5A)
ADP  A   1 ( 4.4A)
ADP  A   1 (-3.0A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.57A 5y9mX-3dlsA:
24.0		 5y9mX-3dlsA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YCN_A_8LXA501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		4 / 6 PHE A1162
CYH A1163
SER A1149
HIS A1126
 None
 1.47A 5ycnA-3dlsA:
0.0		 5ycnA-3dlsA:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF9_B_NIOB401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		5 / 7 VAL A1013
VAL A1026
LYS A1028
ILE A1145
ASP A1146
 ADP  A   1 ( 4.5A)
ADP  A   1 ( 4.4A)
ADP  A   1 (-3.0A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.58A 5yf9B-3dlsA:
23.7		 5yf9B-3dlsA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF9_X_NIOX401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		7 / 9 LEU A1005
VAL A1013
VAL A1026
LYS A1028
ILE A1065
ILE A1145
ASP A1146
 ADP  A   1 (-4.1A)
ADP  A   1 ( 4.5A)
ADP  A   1 ( 4.4A)
ADP  A   1 (-3.0A)
ADP  A   1 (-4.0A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.60A 5yf9X-3dlsA:
24.5		 5yf9X-3dlsA:
13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YWM_X_NIOX403_0
(CASEIN KINASE II
SUBUNIT ALPHA')		 3dls PAS
DOMAIN-CONTAINING
SERINE/THREONINE-PRO
TEIN KINASE
(Homo
sapiens) 		6 / 7 VAL A1013
VAL A1026
LYS A1028
ILE A1065
ILE A1145
ASP A1146
 ADP  A   1 ( 4.5A)
ADP  A   1 ( 4.4A)
ADP  A   1 (-3.0A)
ADP  A   1 (-4.0A)
ADP  A   1 (-4.0A)
MG  A   8 (-2.3A)
 0.49A 5ywmX-3dlsA:
24.4		 5ywmX-3dlsA:
13.53